Quiz (Meeting Coverage)
PhysQuiz on APA 2021: Tardive Dyskinesia
Are you caught up on trials on tardive dyskinesia presented on APA 2021? Test your knowledge! 1. A...
Read More
PhysQuiz on AAN 2021: Multiple Sclerosis
Are you caught up on trials on multiple sclerosis that have been released from AAN 2021? Test your...
Read MorePhysQuiz Answers! APA 2021: Tardive Dyskinesia
How did you do? 1) A post-hoc analysis of AIMS data from a long-term valbenazine study, KINECT 4 to assess the patterns of improvement of patients with TD found that what percentage of patients receiving valbenazine met...
Read More
PhysQuiz on ASCO GU: Renal Carcinoma
Are you caught up on breaking trial results released at ASCO GU? Test your knowledge on our Renal...
Read More
Take Our PhysQuiz on ACR Convergence 2020!
Test your knowledge on results on PsA released at ACR Convergence 2020 – take our quiz and...
Read MorePhysQuiz Answers! SABCS 2020
1) In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer ADC trastuzumab deruxtecan (Enhertu) continued to demonstrate favorable data, including a median progression-free...
Read More
Take Our PhysQuiz on SABCS 2020!
Test your knowledge on SABCS 2020 – take our quiz and see how you compare with your...
Read MorePhysQuiz Answers! AAN 2021: Multiple Sclerosis
Which of the following is a preliminary outcome of the retrospective, multi-center observational study in a cohort of Italian MS patients investigating the impact of disease-modifying treatments on COVID-19 course of disease?a)...
Read MorePhysQuiz Answers! A Focus on Allergic Asthma
Thank you for taking our quiz on allergic asthma! How did you do? 1) What percent of patients diagnosed with severe asthma (mean age of 12 years) were drug adherent, according to a study presented at AAAAI? a) 43% b) 57% c) 68%...
Read MorePhysQuiz Answers! A Focus on Chronic Idiopathic Urticaria
Thank you for taking our quiz on chronic urticaria! How did you do? 1) The NCBI recently released recommendations for diagnosis and management of chronic idiopathic urticaria, recommends using a skin prick test as part of...
Read MorePhysQuiz Answers! ASCO GU: Renal Cell Carcinoma
1) Results released from the Phase 3 CLEAR Trial found that lenvatinib combined with EITHER of these two drugs demonstrated significant benefits over sunitinib in patients with advanced RCC: a) pembrolizumab or...
Read MorePhysQuiz Answers! ACR Convergence 2020
Thank you for taking our quiz on PsA from results presented at ACR Convergence 2020! How did you do? 1) DMARD-naïve patients achieving Routine Assessment of Patient Index Data 3 (RAPID3) and the Clinical Disease Activity for...
Read More